Literature DB >> 29249545

Burden of medically attended influenza infection and cases averted by vaccination - United States, 2013/14 through 2015/16 influenza seasons.

Michael L Jackson1, C Hallie Phillips2, Joyce Benoit2, Lisa A Jackson2, Manjusha Gaglani3, Kempapura Murthy3, Huong Q McLean4, Edward A Belongia4, Ryan Malosh5, Richard Zimmerman6, Brendan Flannery7.   

Abstract

BACKGROUND: In addition to preventing hospitalizations and deaths due to influenza, influenza vaccination programs can reduce the burden of outpatient visits for influenza. We estimated the incidence of medically-attended influenza at three geographically diverse sites in the United States, and the cases averted by vaccination, for the 2013/14 through 2015/16 influenza seasons.
METHODS: We defined surveillance populations at three sites from the United States Influenza Vaccine Effectiveness Network. Among these populations, we identified outpatient visits laboratory-confirmed influenza via active surveillance, and identified all outpatient visits for acute respiratory illness from healthcare databases. We extrapolated the total number of outpatient visits for influenza from the proportion of surveillance visits with a positive influenza test. We combined estimates of incidence, vaccine coverage, and vaccine effectiveness to estimate outpatient visits averted by vaccination.
RESULTS: Across the three sites and seasons, incidence of medically attended influenza ranged from 14 to 54 per 1000 population. Incidence was highest in children aged 6 months to 9 years (33 to 70 per 1000) and lowest in adults aged 18-49 years (21 to 27 per 1000). Cases averted ranged from 9 per 1000 vaccinees (Washington, 2014/15) to 28 per 1000 (Wisconsin, 2013/14). DISCUSSION: Seasonal influenza epidemics cause a considerable burden of outpatient medical visits. The United States influenza vaccination program has caused meaningful reductions in outpatient visits for influenza, even in years when the vaccine is not well-matched to the dominant circulating influenza strain.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Incidence; Influenza, human; Influenza, vaccines

Mesh:

Substances:

Year:  2017        PMID: 29249545      PMCID: PMC5843364          DOI: 10.1016/j.vaccine.2017.12.014

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  23 in total

1.  Early estimates of seasonal influenza vaccine effectiveness in Europe among target groups for vaccination: results from the I-MOVE multicentre case-control study, 2011/12.

Authors:  E Kissling; M Valenciano
Journal:  Euro Surveill       Date:  2012-04-12

2.  Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates.

Authors:  Suzanne E Ohmit; Mark G Thompson; Joshua G Petrie; Swathi N Thaker; Michael L Jackson; Edward A Belongia; Richard K Zimmerman; Manjusha Gaglani; Lois Lamerato; Sarah M Spencer; Lisa Jackson; Jennifer K Meece; Mary Patricia Nowalk; Juhee Song; Marcus Zervos; Po-Yung Cheng; Charles R Rinaldo; Lydia Clipper; David K Shay; Pedro Piedra; Arnold S Monto
Journal:  Clin Infect Dis       Date:  2013-11-13       Impact factor: 9.079

3.  The annual production cycle for influenza vaccine.

Authors:  Catherine Gerdil
Journal:  Vaccine       Date:  2003-05-01       Impact factor: 3.641

Review 4.  A systematic review of clinical decision rules for the diagnosis of influenza.

Authors:  Mark H Ebell; Anna Afonso
Journal:  Ann Fam Med       Date:  2011 Jan-Feb       Impact factor: 5.166

5.  Validation of Health Event Capture in the Marshfield Epidemiologic Study Area.

Authors:  Amy L Kieke; Burney A Kieke; Sarah L Kopitzke; David L McClure; Edward A Belongia; Jeffrey J VanWormer; Robert T Greenlee
Journal:  Clin Med Res       Date:  2014-12-08

6.  Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season.

Authors:  Edward A Belongia; Burney A Kieke; James G Donahue; Robert T Greenlee; Amanda Balish; Angie Foust; Stephen Lindstrom; David K Shay
Journal:  J Infect Dis       Date:  2009-01-15       Impact factor: 5.226

7.  Underestimation of the role of pneumonia and influenza in causing excess mortality.

Authors:  W H Barker; J P Mullooly
Journal:  Am J Public Health       Date:  1981-06       Impact factor: 9.308

8.  Influenza vaccine effectiveness in the United States during 2012-2013: variable protection by age and virus type.

Authors:  Huong Q McLean; Mark G Thompson; Maria E Sundaram; Burney A Kieke; Manjusha Gaglani; Kempapura Murthy; Pedro A Piedra; Richard K Zimmerman; Mary Patricia Nowalk; Jonathan M Raviotta; Michael L Jackson; Lisa Jackson; Suzanne E Ohmit; Joshua G Petrie; Arnold S Monto; Jennifer K Meece; Swathi N Thaker; Jessie R Clippard; Sarah M Spencer; Alicia M Fry; Edward A Belongia
Journal:  J Infect Dis       Date:  2014-11-18       Impact factor: 5.226

9.  Estimated influenza illnesses and hospitalizations averted by vaccination--United States, 2013-14 influenza season.

Authors:  Carrie Reed; Inkyu Kevin Kim; James A Singleton; Sandra S Chaves; Brendan Flannery; Lyn Finelli; Alicia Fry; Erin Burns; Paul Gargiullo; Daniel Jernigan; Nancy Cox; Joseph Bresee
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-12-12       Impact factor: 17.586

10.  Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2015-16 Influenza Season.

Authors:  Lisa A Grohskopf; Leslie Z Sokolow; Sonja J Olsen; Joseph S Bresee; Karen R Broder; Ruth A Karron
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-08-07       Impact factor: 17.586

View more
  8 in total

Review 1.  Influenza Vaccination in Older Adults: Recent Innovations and Practical Applications.

Authors:  Melissa K Andrew; Susan K Bowles; Graham Pawelec; Laura Haynes; George A Kuchel; Shelly A McNeil; Janet E McElhaney
Journal:  Drugs Aging       Date:  2019-01       Impact factor: 3.923

2.  A model of influenza infection and vaccination in children aged under 5 years in Beijing, China.

Authors:  Yi Zhang; David J Muscatello; Zhidong Cao; Abrar A Chughtai; Valentina Costantino; Daitao Zhang; Peng Yang; Quanyi Wang; C Raina MacIntyre
Journal:  Hum Vaccin Immunother       Date:  2020-01-29       Impact factor: 3.452

3.  Estimated influenza illnesses and hospitalizations averted by influenza vaccination among children aged 6-59 months in Suzhou, China, 2011/12 to 2015/16 influenza seasons.

Authors:  Wanqing Zhang; Junmei Gao; Liling Chen; Jianmei Tian; Matthew Biggerstaff; Suizan Zhou; Sujian Situ; Yin Wang; Jun Zhang; Alexander J Millman; Carolyn M Greene; Tao Zhang; Genming Zhao
Journal:  Vaccine       Date:  2020-11-08       Impact factor: 3.641

4.  Use of self-reported vaccination status can bias vaccine effectiveness estimates from test-negative studies.

Authors:  Michael L Jackson
Journal:  Vaccine X       Date:  2018-12-29

Review 5.  Influenza virus-related critical illness: prevention, diagnosis, treatment.

Authors:  Eric J Chow; Joshua D Doyle; Timothy M Uyeki
Journal:  Crit Care       Date:  2019-06-12       Impact factor: 9.097

6.  Impact of national influenza vaccination strategy in severe influenza outcomes among the high-risk Portuguese population.

Authors:  Ausenda Machado; Irina Kislaya; Amparo Larrauri; Carlos Matias Dias; Baltazar Nunes
Journal:  BMC Public Health       Date:  2019-12-16       Impact factor: 3.295

7.  Preventing the Risk of Hospitalization for Respiratory Complications of Influenza among the Elderly: Is There a Better Influenza Vaccination Strategy? A Retrospective Population Study.

Authors:  Silvia Cocchio; Tolinda Gallo; Stefania Del Zotto; Elena Clagnan; Andrea Iob; Patrizia Furlan; Marco Fonzo; Chiara Bertoncello; Vincenzo Baldo
Journal:  Vaccines (Basel)       Date:  2020-06-28

8.  Impact of influenza vaccination programmes among the elderly population on primary care, Portugal, Spain and the Netherlands: 2015/16 to 2017/18 influenza seasons.

Authors:  Ausenda Machado; Clara Mazagatos; Frederika Dijkstra; Irina Kislaya; Alin Gherasim; Scott A McDonald; Esther Kissling; Marta Valenciano; Adam Meijer; Mariëtte Hooiveld; Baltazar Nunes; Amparo Larrauri
Journal:  Euro Surveill       Date:  2019-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.